Occupational Intakes of Radionuclides Part 1 - ICRP
Occupational Intakes of Radionuclides Part 1 - ICRP
Occupational Intakes of Radionuclides Part 1 - ICRP
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2592<br />
2593<br />
2594<br />
2595<br />
2596<br />
2597<br />
2598<br />
2599<br />
2600<br />
2601<br />
2602<br />
2603<br />
2604<br />
2605<br />
2606<br />
2607<br />
2608<br />
2609<br />
2610<br />
2611<br />
2612<br />
2613<br />
2614<br />
2615<br />
2616<br />
2617<br />
2618<br />
2619<br />
2620<br />
2621<br />
2622<br />
2623<br />
2624<br />
2625<br />
DRAFT REPORT FOR CONSULTATION<br />
kinetics'). Similarly, element-specific bound state parameter values would be expected<br />
to apply to decay products formed in the respiratory tract. However, analysis carried<br />
out by the Task Group showed that application <strong>of</strong> independent kinetics rather than<br />
shared kinetics within the respiratory tract, to decay products <strong>of</strong> Type F radionuclides,<br />
would make little difference to respiratory tract tissue dose coefficients (up to a factor<br />
<strong>of</strong> two, but in most cases much less), and less difference to effective dose coefficients.<br />
For Type F materials absorption to blood is rapid and doses from deposition in<br />
systemic tissues will <strong>of</strong>ten make greater contributions to effective dose than doses to<br />
respiratory tract tissues. The additional complexity involved in application <strong>of</strong><br />
independent kinetics was therefore considered to be unjustified. Furthermore, in many<br />
practical exposure situations, an intake <strong>of</strong> a parent nuclide will <strong>of</strong>ten be accompanied<br />
by simultaneous intakes <strong>of</strong> its decay products. Their activities (which, being treated as<br />
separate intakes will be given absorption kinetics appropriate to the element) will<br />
<strong>of</strong>ten be considerably greater than the activities <strong>of</strong> decay products formed within the<br />
respiratory tract, because very little decay <strong>of</strong> the parent takes place before a Type F<br />
material is absorbed into blood.<br />
(167) Thus, in this series <strong>of</strong> documents, radioactive decay products formed within<br />
the respiratory tract (with the exception <strong>of</strong> noble gases) are assumed by default to<br />
follow the absorption behaviour <strong>of</strong> the parent nuclide, and are given the same<br />
dissolution and uptake parameter values as the parent (shared kinetics). Following<br />
absorption to blood, they are assumed to behave according to the systemic model<br />
applied to the element as a daughter <strong>of</strong> the parent radionuclide.<br />
(168) Nevertheless, where experimental results are available which allow direct<br />
comparison between the absorption behaviour <strong>of</strong> a parent radionuclide, and that <strong>of</strong> its<br />
radioactive decay products, they are summarised in the inhalation section <strong>of</strong> the<br />
parent element (e.g. uranium, thorium). Such information may be <strong>of</strong> use to those<br />
carrying out individual monitoring, especially if intakes <strong>of</strong> a parent are being assessed<br />
by means <strong>of</strong> measurements on one or more <strong>of</strong> its decay products. The behaviour <strong>of</strong><br />
thorium and its decay products can be <strong>of</strong> particular importance in this context,<br />
because there is generally significant long-term retention <strong>of</strong> thorium in the lungs<br />
following its deposition in soluble form, whereas soluble forms <strong>of</strong> important decay<br />
products, notably radium and lead, are absorbed relatively readily.<br />
73